Neurocrine Biosciences, Inc. $(NBIX)$ is currently at $124.16, up $14.41 or 13.13%
--Would be highest close since Feb. 6, 2025, when it closed at $150.51
--On pace for largest percent increase since Nov. 2, 2017, when it rose 19.45%
--Currently up five of the past six days
--Currently up three consecutive days; up 16.48% over this period
--Best three day stretch since the three days ending March 26, 2020, when it rose 17.1%
--Down 9.04% year-to-date
--Down 19% from its all-time closing high of $153.29 on Jan. 30, 2025
--Down 13.29% from 52 weeks ago (May 7, 2024), when it closed at $143.19
--Down 19% from its 52-week closing high of $153.29 on Jan. 30, 2025
--Up 41.83% from its 52-week closing low of $87.54 on April 8, 2025
--Traded as high as $130.46; highest intraday level since Feb. 7, 2025, when it hit $132.00
--Up 18.87% at today's intraday high; largest intraday percent increase since Nov. 2, 2017, when it rose as much as 23.03%
All data as of 10:00:13 AM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
May 06, 2025 10:02 ET (14:02 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.